.png)
Join 3,000+ toxicologists learning how nonclinical actually works:
.png)
A newsletter on toxicology and drug development — how it actually works.
The Nonclinical is a free bi-weekly newsletter for early-career toxicologists, PhD students, and DABT candidates who want to understand nonclinical drug development from the inside out.
Every issue covers:
-
How study designs actually get made
-
Species selection and why it matters
-
GLP requirements and what regulators look for
-
IND-enabling strategy and the decisions behind it
-
How safety calls get made in real programs
No textbook theory. Just the stuff that matters when you're actually doing the work.
Written by Dessi McEntee, MS, DABT
— Board-certified toxicologist
— Fractional Head of Toxicology
— Author of Data Is Not Strategy
.png)